Feasibility, Process, and Outcomes of Cardiovascular Clinical Trial Data Sharing: A Reproduction Analysis of the SMART-AF Trial.

Abstract:

Importance:Data sharing is as an expanding initiative for enhancing trust in the clinical research enterprise. Objective:To evaluate the feasibility, process, and outcomes of a reproduction analysis of the THERMOCOOL SMARTTOUCH Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (SMART-AF) trial using shared clinical trial data. Design, Setting, and Participants:A reproduction analysis of the SMART-AF trial was performed using the data sets, data dictionary, case report file, and statistical analysis plan from the original trial accessed through the Yale Open Data Access Project using the SAS Clinical Trials Data Transparency platform. SMART-AF was a multicenter, single-arm trial evaluating the effectiveness and safety of an irrigated, contact force-sensing catheter for ablation of drug refractory, symptomatic paroxysmal atrial fibrillation in 172 participants recruited from 21 sites between June 2011 and December 2011. Analysis of the data was conducted between December 2016 and April 2017. Main Outcomes and Measures:Effectiveness outcomes included freedom from atrial arrhythmias after ablation and proportion of participants without any arrhythmia recurrence over the 12 months of follow-up after a 3-month blanking period. Safety outcomes included major adverse device- or procedure-related events. Results:The SMART AF trial participants' mean age was 58.7 (10.8) years, and 72% were men. The time from initial proposal submission to final analysis was 11 months. Freedom from atrial arrhythmias at 12 months postprocedure was similar compared with the primary study report (74.0%; 95% CI, 66.0-82.0 vs 76.4%; 95% CI, 68.7-84.1). The reproduction analysis success rate was higher than the primary study report (65.8%; 95% CI 56.5-74.2 vs 75.6%; 95% CI, 67.2-82.5). Adverse events were minimal and similar between the 2 analyses, but contact force range or regression models could not be reproduced. Conclusions and Relevance:The feasibility of a reproduction analysis of the SMART-AF trial was demonstrated through an academic data-sharing platform. Data sharing can be facilitated through incentivizing collaboration, sharing statistical code, and creating more decentralized data sharing platforms with fewer restrictions to data access.

journal_name

JAMA Cardiol

journal_title

JAMA cardiology

authors

Gay HC,Baldridge AS,Huffman MD

doi

10.1001/jamacardio.2017.3808

subject

Has Abstract

pub_date

2017-12-01 00:00:00

pages

1375-1379

issue

12

eissn

2380-6583

issn

2380-6591

pii

2657542

journal_volume

2

pub_type

杂志文章
  • Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

    abstract:Importance:Persons with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved longevity but face an elevated risk of myocardial infarction (MI) due to common MI risk factors and HIV-specific factors. Despite these elevated MI rates, optimal methods to predict MI risks for HIV-infe...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2016.4494

    authors: Feinstein MJ,Nance RM,Drozd DR,Ning H,Delaney JA,Heckbert SR,Budoff MJ,Mathews WC,Kitahata MM,Saag MS,Eron JJ,Moore RD,Achenbach CJ,Lloyd-Jones DM,Crane HM

    更新日期:2017-02-01 00:00:00

  • Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.

    abstract:Importance:There are major gaps in use of guideline-directed medical therapy (GDMT) for patients with heart failure (HF). Patient-reported data outlining patient goals and preferences associated with GDMT are not available. Objective:To survey patients with chronic HF to better understand their experiences and percept...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.4987

    authors: Samsky MD,Lin L,Greene SJ,Lippmann SJ,Peterson PN,Heidenreich PA,Laskey WK,Yancy CW,Greiner MA,Hardy NC,Kavati A,Park S,Mentz RJ,Fonarow GC,O'Brien EC

    更新日期:2020-03-01 00:00:00

  • Cardiac Stress Test Trends Among US Patients Younger Than 65 Years, 2005-2012.

    abstract:Importance:After a period of rapid growth, use of cardiac stress testing has recently decreased among Medicare beneficiaries and in a large integrated health system. However, it is not known whether declines in cardiac stress testing are universal or are confined to certain populations. Objective:To determine trends i...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.3153

    authors: Kini V,McCarthy FH,Dayoub E,Bradley SM,Masoudi FA,Ho PM,Groeneveld PW

    更新日期:2016-12-01 00:00:00

  • Outcomes of Care for Ischemic Heart Disease and Chronic Heart Failure in the Veterans Health Administration.

    abstract:Importance:The Department of Veterans Affairs (VA) operates a nationwide system of hospitals and hospital-affiliated clinics, providing health care to more than 2 million veterans with cardiovascular disease. While data permitting hospital comparisons of the outcomes of acute cardiovascular care (eg, myocardial infarct...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2018.1115

    authors: Groeneveld PW,Medvedeva EL,Walker L,Segal AG,Richardson DM,Epstein AJ

    更新日期:2018-07-01 00:00:00

  • Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.

    abstract:Importance:Improvements in symptoms, functional capacity, and quality of life are among the key goals of edge-to-edge transcatheter mitral valve repair (TMVR) for mitral regurgitation. Objective:To examine health status outcomes among patients undergoing TMVR in clinical practice and the factors associated with improv...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2018.3359

    authors: Arnold SV,Li Z,Vemulapalli S,Baron SJ,Mack MJ,Kosinski AS,Reynolds MR,Hermiller JB,Rumsfeld JS,Cohen DJ

    更新日期:2018-12-01 00:00:00

  • Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

    abstract:Importance:Strategies for reliable selection of high-risk patients with hypertrophic cardiomyopathy (HCM) for prevention of sudden cardiac death (SCD) with implantable cardioverter/defibrillators (ICDs) are incompletely resolved. Objective:To assess the reliability of SCD prediction methods leading to prophylactic ICD...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.1391

    authors: Maron MS,Rowin EJ,Wessler BS,Mooney PJ,Fatima A,Patel P,Koethe BC,Romashko M,Link MS,Maron BJ

    更新日期:2019-07-01 00:00:00

  • Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.

    abstract:Importance:Low-density lipoprotein cholesterol (LDL-C) is an important modifiable risk factor for atherosclerotic cardiovascular disease. It is unclear whether the percentage LDL-C lowering with pharmacotherapies differs on the basis of baseline LDL-C levels. Objective:To evaluate the association between baseline LDL-...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.6184

    authors: Marcusa DP,Giugliano RP,Park JG,de Lemos JA,Cannon CP,Sabatine MS

    更新日期:2020-11-13 00:00:00

  • Understanding the Role of P Values and Hypothesis Tests in Clinical Research.

    abstract::P values and hypothesis testing methods are frequently misused in clinical research. Much of this misuse appears to be owing to the widespread, mistaken belief that they provide simple, reliable, and objective triage tools for separating the true and important from the untrue or unimportant. The primary focus in inter...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.3312

    authors: Mark DB,Lee KL,Harrell FE Jr

    更新日期:2016-12-01 00:00:00

  • Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.

    abstract:Importance:Use of transcatheter aortic valve replacement (TAVR) for severe aortic stenosis is growing rapidly. However, to our knowledge, the durability of these prostheses is incompletely defined. Objective:To determine the midterm hemodynamic performance of balloon-expandable transcatheter heart valves. Design, Set...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,随机对照试验

    doi:10.1001/jamacardio.2017.3306

    authors: Douglas PS,Leon MB,Mack MJ,Svensson LG,Webb JG,Hahn RT,Pibarot P,Weissman NJ,Miller DC,Kapadia S,Herrmann HC,Kodali SK,Makkar RR,Thourani VH,Lerakis S,Lowry AM,Rajeswaran J,Finn MT,Alu MC,Smith CR,Blackstone EH,

    更新日期:2017-11-01 00:00:00

  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure: Proposal of a Novel Mechanism of Action.

    abstract:Importance:Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducing the risk of the development or progression of heart failure. In a landmark trial called Empagliflozin, Cardiovascular Outcomes, and M...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.2275

    authors: Packer M,Anker SD,Butler J,Filippatos G,Zannad F

    更新日期:2017-09-01 00:00:00

  • Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project.

    abstract:Importance:Physicians have been criticized for having an overly enthusiastic response to new device approvals, especially for novel technologies. However, to our knowledge, the rates of new product adoption and patterns of new device usage in clinical practice have not been well described. Objective:To characterize th...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.0388

    authors: Chau KH,Kennedy KF,Messenger JC,Garratt KN,Maddox TM,Yeh RW,Kirtane AJ

    更新日期:2019-06-01 00:00:00

  • Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.

    abstract:Importance:The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated the benefit of lowering systolic blood pressure (SBP) to 120 mm Hg, yet other trials, such as Heart Outcomes Prevention Evaluation-3 (HOPE-3), did not find consistent benefit. How to incorporate these results into the treatment of those wit...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.2861

    authors: Navar AM,Pencina MJ,Peterson ED

    更新日期:2016-11-01 00:00:00

  • Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.

    abstract:Importance:Limited evidence is available regarding the benefit and hazard of higher-intensity treatment to lower lipid levels among patients 75 years or older. As a result, guideline recommendations differ for this age group compared with younger patients. Objective:To determine the effect on outcomes and risks of com...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1001/jamacardio.2019.2306

    authors: Bach RG,Cannon CP,Giugliano RP,White JA,Lokhnygina Y,Bohula EA,Califf RM,Braunwald E,Blazing MA

    更新日期:2019-09-01 00:00:00

  • Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting.

    abstract:IMPORTANCE:Reduced rates of cardiac catheterization, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) are an unintended consequence of public reporting of cardiogenic shock outcomes in New York. OBJECTIVES:To evaluate whether the referral rates for cardiac catheterization, PCI, or CABG...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.0785

    authors: Bangalore S,Guo Y,Xu J,Blecker S,Gupta N,Feit F,Hochman JS

    更新日期:2016-09-01 00:00:00

  • Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure.

    abstract:Importance:Medicare Advantage (MA), a private insurance plan option, now covers one-third of all Medicare beneficiaries. Although patients with cardiovascular disease enrolled in MA have been reported to receive higher quality of care in the ambulatory setting than patients enrolled in fee-for-service (FFS) Medicare, i...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.3638

    authors: Figueroa JF,Wadhera RK,Frakt AB,Fonarow GC,Heidenreich PA,Xu H,Lytle B,DeVore AD,Matsouaka R,Yancy CW,Bhatt DL,Joynt Maddox KE

    更新日期:2020-09-02 00:00:00

  • Outpatient Worsening Heart Failure as a Target for Therapy: A Review.

    abstract:Importance:Hospitalizations for worsening heart failure (WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient-centered outcome. In thi...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.5250

    authors: Greene SJ,Mentz RJ,Felker GM

    更新日期:2018-03-01 00:00:00

  • Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.

    abstract:Importance:Cohort studies have reported increased incidence of cardiovascular disease (CVD) among individuals with low vitamin D status. To date, randomized clinical trials of vitamin D supplementation have not found an effect, possibly because of using too low a dose of vitamin D. Objective:To examine whether monthly...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,随机对照试验

    doi:10.1001/jamacardio.2017.0175

    authors: Scragg R,Stewart AW,Waayer D,Lawes CMM,Toop L,Sluyter J,Murphy J,Khaw KT,Camargo CA Jr

    更新日期:2017-06-01 00:00:00

  • Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

    abstract:IMPORTANCE:Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2015.0304

    authors: Mendelson MM,Lyass A,O'Donnell CJ,D'Agostino RB Sr,Levy D

    更新日期:2016-04-01 00:00:00

  • Diagnostic Accuracy of Computed Tomography-Derived Fractional Flow Reserve : A Systematic Review.

    abstract:Importance:Computed tomography-derived fractional flow reserve (FFR-CT) is a novel, noninvasive test for myocardial ischemia. Clinicians using FFR-CT must be able to interpret individual FFR-CT results to determine subsequent patient care. Objective:To provide clinicians a means of interpreting individual FFR-CT resul...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.1314

    authors: Cook CM,Petraco R,Shun-Shin MJ,Ahmad Y,Nijjer S,Al-Lamee R,Kikuta Y,Shiono Y,Mayet J,Francis DP,Sen S,Davies JE

    更新日期:2017-07-01 00:00:00

  • Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study.

    abstract:Importance:The Open-Label Study of Long-term Evaluation Against LDL-C (OSLER-1) evaluated the durability of long-term efficacy and safety during long-term therapy with evolocumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9). Objective:To determine whether LDL-C level reductions ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.0747

    authors: Koren MJ,Sabatine MS,Giugliano RP,Langslet G,Wiviott SD,Kassahun H,Ruzza A,Ma Y,Somaratne R,Raal FJ

    更新日期:2017-06-01 00:00:00

  • Resuscitation Practices Associated With Survival After In-Hospital Cardiac Arrest: A Nationwide Survey.

    abstract:IMPORTANCE:Although survival of patients with in-hospital cardiac arrest varies markedly among hospitals, specific resuscitation practices that distinguish sites with higher cardiac arrest survival rates remain unknown. OBJECTIVE:To identify resuscitation practices associated with higher rates of in-hospital cardiac a...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.0073

    authors: Chan PS,Krein SL,Tang F,Iwashyna TJ,Harrod M,Kennedy M,Lehrich J,Kronick S,Nallamothu BK,American Heart Association's Get With the Guidelines–Resuscitation Investigators.

    更新日期:2016-05-01 00:00:00

  • Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.

    abstract:Importance:Many of the quality measures used to assess accountable care organization (ACO) performance in the Medicare Shared Savings Program (MSSP) focus on disease control and medication use among patients with cardiovascular disease and diabetes. To date, the association between participation in the MSSP by provider...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.2172

    authors: McWilliams JM,Najafzadeh M,Shrank WH,Polinski JM

    更新日期:2017-09-01 00:00:00

  • Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis.

    abstract:Importance:Observational studies have reported an association between low serum vitamin D levels and elevated risk of cardiovascular disease (CVD) events, but such studies cannot prove causation because of possible unmeasured confounding. Objective:We conducted a meta-analysis of randomized clinical trials that tested...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,meta分析

    doi:10.1001/jamacardio.2019.1870

    authors: Barbarawi M,Kheiri B,Zayed Y,Barbarawi O,Dhillon H,Swaid B,Yelangi A,Sundus S,Bachuwa G,Alkotob ML,Manson JE

    更新日期:2019-08-01 00:00:00

  • Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study.

    abstract:Importance:Electronic health record (EHR) biobanks containing clinical and genomic data on large numbers of individuals have great potential to inform drug discovery. Individuals with interleukin 6 receptor (IL6R) single-nucleotide polymorphisms (SNPs) who are not receiving IL6R blocking therapy have biomarker profiles...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2018.2287

    authors: Cai T,Zhang Y,Ho YL,Link N,Sun J,Huang J,Cai TA,Damrauer S,Ahuja Y,Honerlaw J,Huang J,Costa L,Schubert P,Hong C,Gagnon D,Sun YV,Gaziano JM,Wilson P,Cho K,Tsao P,O'Donnell CJ,Liao KP,VA Million Veteran Program.

    更新日期:2018-09-01 00:00:00

  • Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.

    abstract:Importance:Quality of percutaneous coronary intervention (PCI) is commonly assessed by risk-adjusted mortality. However, this metric may result in procedural risk aversion, especially for high-risk patients. Objective:To determine correlation and reclassification between hospital-level disease-specific mortality and P...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2020.0753

    authors: Nathan AS,Xiang Q,Wojdyla D,Khatana SAM,Dayoub EJ,Wadhera RK,Bhatt DL,Kolansky DM,Kirtane AJ,Rao SV,Yeh RW,Groeneveld PW,Wang TY,Giri J

    更新日期:2020-07-01 00:00:00

  • Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.

    abstract:Importance:The period following heart failure hospitalization (HFH) is a vulnerable time with high rates of death or recurrent HFH. Objective:To evaluate clinical characteristics, outcomes, and treatment response to vericiguat according to prespecified index event subgroups and time from index HFH in the Vericiguat Gl...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.6455

    authors: Lam CSP,Giczewska A,Sliwa K,Edelmann F,Refsgaard J,Bocchi E,Ezekowitz JA,Hernandez AF,O'Connor CM,Roessig L,Patel MJ,Pieske B,Anstrom KJ,Armstrong PW,VICTORIA Study Group.

    更新日期:2020-11-13 00:00:00

  • Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life.

    abstract:Importance:Long-term blood pressure (BP) variability has emerged as a reproducible measure that is associated with heart failure independent of systemic BP. Visit-to-visit BP variability may be associated with the risk of heart failure early in the life course and thus may be reflected in subclinical alterations in car...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2020.0799

    authors: Nwabuo CC,Yano Y,Moreira HT,Appiah D,Vasconcellos HD,Aghaji QN,Viera A,Rana JS,Shah RV,Murthy VL,Allen NB,Schreiner PJ,Lloyd-Jones DM,Lima JAC

    更新日期:2020-07-01 00:00:00

  • Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.

    abstract:Importance:It is unknown whether coronary revascularization, when added to optimal medical therapy, improves prognosis in patients with stable ischemic heart disease (SIHD) at increased risk of cardiovascular events owing to moderate or severe ischemia. Objective:To describe baseline characteristics of participants en...

    journal_title:JAMA cardiology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1001/jamacardio.2019.0014

    authors: Hochman JS,Reynolds HR,Bangalore S,O'Brien SM,Alexander KP,Senior R,Boden WE,Stone GW,Goodman SG,Lopes RD,Lopez-Sendon J,White HD,Maggioni AP,Shaw LJ,Min JK,Picard MH,Berman DS,Chaitman BR,Mark DB,Spertus JA,Cyr D

    更新日期:2019-03-01 00:00:00

  • Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.

    abstract:Importance:With improved survival, heart failure (HF) has become a major complication for individuals with human immunodeficiency virus (HIV) infection. It is unclear if this risk extends to different types of HF in the antiretroviral therapy (ART) era. Determining whether HIV infection is associated with HF with reduc...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.0264

    authors: Freiberg MS,Chang CH,Skanderson M,Patterson OV,DuVall SL,Brandt CA,So-Armah KA,Vasan RS,Oursler KA,Gottdiener J,Gottlieb S,Leaf D,Rodriguez-Barradas M,Tracy RP,Gibert CL,Rimland D,Bedimo RJ,Brown ST,Goetz MB,Warner

    更新日期:2017-05-01 00:00:00

  • Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

    abstract:Importance:Bioresorbable scaffolds were designed to provide clinical benefits after their complete bioresorption. Prior studies demonstrated early risks with the Absorb polymeric bioresorbable vascular scaffold (BVS). Whether this risk profile changes over time during the course of its bioresorption is unknown. Object...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,meta分析

    doi:10.1001/jamacardio.2019.4101

    authors: Stone GW,Kimura T,Gao R,Kereiakes DJ,Ellis SG,Onuma Y,Chevalier B,Simonton C,Dressler O,Crowley A,Ali ZA,Serruys PW

    更新日期:2019-12-01 00:00:00